Insomnia is the most common sleep disorder with huge socio-economic costs. According to the third edition of the International Classification of Sleep Disorders (ICSD-3), it is characterized by difficulty in either initiating sleep, maintaining sleep continuity, or poor sleep quality. However, Chronic Insomnia is more complex, accompanied by daytime impairment of cognition, mood, or performance.
The Chronic Insomnia Market report offers a comprehensive analysis of the disease overview, its causes, signs/ symptoms, and diagnosis modalities. The report highlights the available treatment, pipeline therapies, and factors changing the Chronic Insomnia market landscape during the study period 2018-30 in the 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan).
The Chronic Insomnia market size insights report is designed to identify and grab true opportunities in the Chronic Insomnia market landscape, help clients form collaborations and ink deals that give them a competitive advantage and plan strategic moves to yield maximum returns.
Some key facts of the Chronic Insomnia market report:
Interested in learning more? Request for Sample @ Chronic Insomnia Market Analysis and Forecast
Various studies worldwide have shown the prevalence of insomnia in 10–30% of the population, some even as high as 50–60%. As per DelveInsight’s Chronic Insomnia epidemiological analysis, Chronic Insomnia is slightly more prevalent among females than males.
The Chronic Insomnia market report offers historical and forecasted epidemiological analysis during the study period 2018-30 in the 7MM segmented into:
For more insights, visit Chronic Insomnia Epidemiological Analysis and Forecast
Chronic Insomnia Market
The primary goal of the Chronic Insomnia market is to improve sleeping habits and alleviate symptoms such as distress and dysfunction. It can be managed with the help of psychological therapy, pharmacologic therapy, or a combination of both.
Psychological therapy options present in the Chronic Insomnia market include cognitive behavioral therapy for insomnia (CBT-I), multicomponent behavioral therapy or brief behavioral therapy (BBT) for insomnia, and other interventions, such as stimulus control, relaxation strategies, and sleep restriction.
Benzodiazepines are frequently prescribed to treat insomnia. Five benzodiazepines (estazolam, flurazepam, quazepam, temazepam, and triazolam) are in market as the FDA-approved medications for insomnia management. Non-benzodiazepine hypnotics include zopiclone, zolpidem, and zaleplon. Orexin receptor antagonists, including Dayvigo and Belsomra, recently gained popularity in the Chronic Insomnia market therapy.
Chronic Insomnia Pipeline Therapies
Scope of the Report
Coverage: 7MM (the US, EU5, and Japan)
Study Period: 2018-30
Key Companies: Idorsia Pharmaceuticals, Janssen Pharmaceuticals, Sequential Medicine
Key Chronic Insomnia Pipeline Therapies: Daridorexant, Seltorexant, SM-1
Chronic Insomnia Market Segmentation: By Geography, By Chronic Insomnia Therapies
Analysis: Comparative and conjoint analysis of Chronic Insomnia emerging therapies
Tools used: SWOT analysis, Conjoint Analysis, Porter’s Five Forces, PESTLE analysis, BCG Matrix analysis methods.
Case Studies
KOL’s Views
Analyst’s Views
Table of Contents
1
Key Insights
2
Report Introduction
3
Chronic Insomnia Market Overview at a Glance
4
Executive Summary of Chronic Insomnia
5
Chronic Insomnia Epidemiology and Patient Population
6
Chronic Insomnia Patient Journey
7
Organizations contributing to Chronic Insomnia
8
Treatment Algorithm, Current Treatment, and Medical Practices
9
Key Endpoints in Chronic Insomnia Clinical Trials
10
Chronic Insomnia Marketed Therapies
11
Chronic Insomnia Emerging Therapies
12
Other Chronic Insomnia Promising Therapies
13
Chronic Insomnia: 7 Major Market Analysis
14
Access and Reimbursement Overview of Chronic Insomnia
15
KOL Reviews
16
Case Reports
17
Chronic Insomnia Market Drivers
18
Chronic Insomnia Market Barriers
19
Chronic Insomnia Market Access
20
SWOT Analysis
21
Disclaimer
22
DelveInsight Capabilities
23
About DelveInsight
DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Know more about our competitive intelligence services.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/chronic-insomnia-market